NUVALENT INC-A (NUVL) Forecast, Price Target & Analyst Ratings
NASDAQ:NUVL • US6707031075
100.11 USD
-0.02 (-0.02%)
Last: Mar 6, 2026, 10:18 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NUVALENT INC-A (NUVL).
Forecast Snapshot
Consensus Price Target
$142.67
+ 42.51% Upside
Next Earnings Forecast
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate-$1.41
Revenue Estimate
ChartMill Buy Consensus
85.83%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$142.67
Upside
+ 42.51%
From current price of $100.11 to mean target of $142.67, Based on 24 analyst forecasts
Low
$121.20
Median
$137.70
High
$172.20
Price Target Revisions
1 Month
-0.01%
3 Months
11.36%
Price Target Summary
24 analysts have analysed NUVL and the average price target is 142.67 USD. This implies a price increase of 42.51% is expected in the next year compared to the current price of 100.11.
The average price target has been revised upward by 11.36% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.83%
NUVL was analyzed by 24 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about NUVL.
In the previous month the buy percentage consensus was at a similar level.
NUVL was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-27 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-12-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-18 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-18 | Baird | Maintains | Outperform -> Outperform |
| 2025-11-18 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-11-17 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-11-17 | Stifel | Maintains | Buy -> Buy |
| 2025-11-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-12 | Canaccord Genuity | Initiate | Buy |
| 2025-10-31 | UBS | Maintains | Buy -> Buy |
| 2025-10-31 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-16 | Stifel | Reiterate | Buy |
| 2025-10-15 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-09-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-09-03 | Raymond James | Initiate | Outperform |
| 2025-08-19 | Piper Sandler | Initiate | Overweight |
| 2025-06-25 | Baird | Maintains | Outperform -> Outperform |
| 2025-06-24 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-06-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-14 | UBS | Upgrade | Neutral -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-30 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate-$1.41
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q-19.14%
Number of Analysts16
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-0.54%
Next Earnings Summary
NUVL is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -1.41 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 1,064.25% | N/A 210.04% | N/A 75.00% | N/A 38.93% | N/A 31.65% | N/A 24.84% | N/A 26.61% | ||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A -81.40% | N/A -84.62% | N/A -79.98% | N/A -64.78% | N/A -6.01% | N/A 23.03% | N/A 88.61% | N/A 291.17% | N/A 560.97% | N/A 100.15% | N/A 24.61% | N/A 21.47% | |
| EBIT YoY % growth | -10.36M | -16.91M -63.22% | -45.82M -170.96% | -86.11M -87.93% | -149.492M -73.61% | -280.368M -87.55% | -414.307M -47.77% | N/A -12.19% | N/A 24.56% | N/A 46.59% | N/A 127.24% | N/A 864.88% | N/A 103.09% | N/A 42.03% | N/A 28.17% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.64 11.01% | -2.16 -31.71% | -3.90 -80.56% | -5.85 -50.00% | N/A 3.20% | N/A 19.15% | N/A 65.44% | N/A 364.02% | N/A 25.90% | N/A 102.75% | N/A 33.32% | N/A 23.71% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -1.41 -19.14% | -1.47 -5.88% | -1.52 10.60% | -1.43 9.27% |
| Revenue Q2Q % growth | 4.748M | 14.283M | ||
| EBITDA Q2Q % growth | -108.153M -29.52% | -111.68M -12.68% | -104.043M 2.42% | -96.543M 16.11% |
| EBIT Q2Q % growth | -113.495M -19.71% | -118.077M -12.92% | -116.585M -3.45% | -113.07M -10.61% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
20.04%
EPS Next 5 Year
23.72%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
24.01%
EBIT Next 5 Year
25.98%
NUVALENT INC-A / NUVL Forecast FAQ
What is the average price target for NUVALENT INC-A (NUVL) stock?
24 analysts have analysed NUVL and the average price target is 142.67 USD. This implies a price increase of 42.51% is expected in the next year compared to the current price of 100.11.
Can you provide the upcoming earnings date for NUVALENT INC-A?
NUVALENT INC-A (NUVL) will report earnings on 2026-05-06.
What are the consensus estimates for NUVL stock next earnings?
The consensus EPS estimate for the next earnings of NUVALENT INC-A (NUVL) is -1.41 USD and the consensus revenue estimate is 0 USD.
How many analysts cover NUVALENT INC-A (NUVL) stock?
The number of analysts covering NUVALENT INC-A (NUVL) is 24.